LianBio

LIANYOTCCIK 1831283HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Reports and events: 49 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

LianBio, Reports and events
Filed	Form	What it is	Accession number
2024-02-2919:45 ET	SC 13D/A	Ownership report, active investor, amended	0001193125-24-053902
2024-02-1307:04 ET	8-K	2.05 Exit or disposal costs; 3.01 Delisting notice; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits	0001831283-24-000004
2023-12-2616:07 ET	8-K	1.01 Entry into a material agreement; 1.02 Termination of a material agreement	0001831283-23-000145
2023-12-2008:05 ET	8-K	5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001831283-23-000141
2023-12-1916:26 ET	8-K	5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001831283-23-000137
2023-12-0616:23 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001831283-23-000133
2023-12-0116:16 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001831283-23-000129
2023-11-3017:08 ET	SC 13D	Ownership report, active investor	0001214659-23-015813
2023-11-1316:28 ET	10-Q	Quarterly reportPeriod 2023-09-30	0001831283-23-000126
2023-11-1316:17 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001831283-23-000124
2023-10-3016:16 ET	8-K	1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001831283-23-000117
2023-08-1416:21 ET	10-Q	Quarterly reportPeriod 2023-06-30	0001831283-23-000110
2023-08-1416:11 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001831283-23-000107
2023-06-2316:17 ET	8-K	5.07 Shareholder vote results	0001831283-23-000092
2023-05-1116:33 ET	10-Q	Quarterly reportPeriod 2023-03-31	0001831283-23-000081
2023-05-1116:23 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001831283-23-000079
2023-05-0107:28 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001831283-23-000073
2023-04-2608:07 ET	8-K	7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits	0001831283-23-000071
2023-04-2116:13 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001831283-23-000067
2023-04-1916:17 ET	DEF 14A	Proxy statementPeriod 2023-06-21	0001831283-23-000061
2023-03-2817:23 ET	10-K	Annual reportPeriod 2022-12-31	0001831283-23-000041
2023-03-2708:40 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001831283-23-000034
2023-03-1716:05 ET	8-K	5.02 Departure or appointment of officers or directors	0001831283-23-000025
2022-12-1907:04 ET	8-K	1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001831283-22-000082
2022-12-1317:03 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001831283-22-000079
2022-11-1016:33 ET	10-Q	Quarterly reportPeriod 2022-09-30	0001831283-22-000075
2022-11-1016:16 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001831283-22-000071
2022-10-1216:20 ET	8-K	8.01 Other events	0001831283-22-000064
2022-08-1116:44 ET	10-Q	Quarterly reportPeriod 2022-06-30	0001831283-22-000061
2022-08-1116:30 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001831283-22-000059
2022-06-1016:14 ET	8-K	5.07 Shareholder vote results	0001831283-22-000044
2022-05-1216:39 ET	10-Q	Quarterly reportPeriod 2022-03-31	0001831283-22-000042
2022-05-1209:15 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001831283-22-000037
2022-04-2708:17 ET	DEF 14A	Proxy statementPeriod 2022-06-08	0001831283-22-000025
2022-04-0816:10 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001831283-22-000021
2022-03-3108:55 ET	10-K	Annual reportPeriod 2021-12-31	0001831283-22-000014
2022-03-3016:55 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001831283-22-000012
2022-03-0216:42 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001831283-22-000005
2022-01-1016:06 ET	10-Q/A	Quarterly report, amendedPeriod 2021-09-30	0001193125-22-005640
2021-12-0917:24 ET	10-Q	Quarterly reportPeriod 2021-09-30	0001193125-21-352813
2021-12-0916:59 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-21-352750
2021-11-1517:03 ET	SC 13D	Ownership report, active investor	0001193125-21-330078
2021-11-1016:30 ET	8-K	1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits	0001193125-21-326065
2021-11-0316:01 ET	8-K	5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits	0001193125-21-318383
2021-10-2918:30 ET	S-1/A	Registration statement, amended	0001193125-21-311645
2021-10-2721:21 ET	S-1/A	Registration statement, amended	0001193125-21-308383
2021-10-2006:09 ET	S-1/A	Registration statement, amended	0001193125-21-302493
2021-10-0817:09 ET	S-1/A	Registration statement, amended	0001193125-21-295616
2021-10-0116:52 ET	S-1	Registration statement	0001193125-21-289805

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.